Procarbazine - Revision history

Lazy at 08:22, 18 January 2025

2025-01-18T08:22:32Z

← Older revision		Revision as of 01:22, 18 January 2025
Line 14:		Line 14:
	did not include the PFS-6 statistic, it did report an unusually high percentage of tumor		did not include the PFS-6 statistic, it did report an unusually high percentage of tumor
	regressions, suggesting that this combination might be effective.		regressions, suggesting that this combination might be effective.
	}}		\|overview=Procarbazine is an FDA-approved chemotherapy drug primarily used for treating glioblastoma, known for its effectiveness when combined with Temodar, as evidenced by a high percentage of tumor regressions. However, it carries a toxicity level of 4, with common side effects including hematological toxicity, nausea, and neurological effects that can significantly impact daily life.}}

69.163.248.232: Updated category= to treatment_category= in TreatmentInfo template

2024-11-12T18:34:35Z

Updated category= to treatment_category= in TreatmentInfo template

← Older revision		Revision as of 11:34, 12 November 2024
Line 8:		Line 8:
	\|usefulness_rating=3		\|usefulness_rating=3
	\|notes=Combination of Temodar and procarbazine showed a high percentage of tumor regressions, suggesting effectiveness.		\|notes=Combination of Temodar and procarbazine showed a high percentage of tumor regressions, suggesting effectiveness.
	\|~~category~~=Other Chemotherapy and Cancer Drugs		\|treatment_category=Other Chemotherapy and Cancer Drugs
	\|toxicity_level=4		\|toxicity_level=4
	\|toxicity_explanation=The drug Procarbazine is considered quite toxic. This rating is based on the common side effects like hematological toxicity, which refers to potential harm to your blood cells, nausea, and neurological effects such as headache or dizziness. These side effects are relatively common and could significantly affect your day-to-day life. Remember, all treatments come with potential risks, and it's important to discuss these with your doctor.		\|toxicity_explanation=The drug Procarbazine is considered quite toxic. This rating is based on the common side effects like hematological toxicity, which refers to potential harm to your blood cells, nausea, and neurological effects such as headache or dizziness. These side effects are relatively common and could significantly affect your day-to-day life. Remember, all treatments come with potential risks, and it's important to discuss these with your doctor.

Lazy at 04:18, 28 March 2024

2024-03-28T04:18:56Z

← Older revision		Revision as of 21:18, 27 March 2024
Line 11:		Line 11:
	\|toxicity_level=4		\|toxicity_level=4
	\|toxicity_explanation=The drug Procarbazine is considered quite toxic. This rating is based on the common side effects like hematological toxicity, which refers to potential harm to your blood cells, nausea, and neurological effects such as headache or dizziness. These side effects are relatively common and could significantly affect your day-to-day life. Remember, all treatments come with potential risks, and it's important to discuss these with your doctor.		\|toxicity_explanation=The drug Procarbazine is considered quite toxic. This rating is based on the common side effects like hematological toxicity, which refers to potential harm to your blood cells, nausea, and neurological effects such as headache or dizziness. These side effects are relatively common and could significantly affect your day-to-day life. Remember, all treatments come with potential risks, and it's important to discuss these with your doctor.
			\|book_text=Temodar has also been combined with procarbazine (64). While the report of that study
			did not include the PFS-6 statistic, it did report an unusually high percentage of tumor
			regressions, suggesting that this combination might be effective.
	}}		}}

Lazy at 16:55, 27 March 2024

2024-03-27T16:55:57Z

← Older revision		Revision as of 09:55, 27 March 2024
Line 9:		Line 9:
	\|notes=Combination of Temodar and procarbazine showed a high percentage of tumor regressions, suggesting effectiveness.		\|notes=Combination of Temodar and procarbazine showed a high percentage of tumor regressions, suggesting effectiveness.
	\|category=Other Chemotherapy and Cancer Drugs		\|category=Other Chemotherapy and Cancer Drugs
			\|toxicity_level=4
			\|toxicity_explanation=The drug Procarbazine is considered quite toxic. This rating is based on the common side effects like hematological toxicity, which refers to potential harm to your blood cells, nausea, and neurological effects such as headache or dizziness. These side effects are relatively common and could significantly affect your day-to-day life. Remember, all treatments come with potential risks, and it's important to discuss these with your doctor.
	}}		}}

Lazy at 13:12, 24 March 2024

2024-03-24T13:12:33Z

← Older revision		Revision as of 06:12, 24 March 2024
Line 9:		Line 9:
	\|notes=Combination of Temodar and procarbazine showed a high percentage of tumor regressions, suggesting effectiveness.		\|notes=Combination of Temodar and procarbazine showed a high percentage of tumor regressions, suggesting effectiveness.
	\|category=Other Chemotherapy and Cancer Drugs		\|category=Other Chemotherapy and Cancer Drugs
			}}

Lazy: Created page with "{{TreatmentInfo |drug_name=Procarbazine |FDA_approval=Yes |used_for=Glioblastoma |clinical_trial_phase=Not specified |common_side_effects=Hematological toxicity, nausea, and neurological effects |OS_with=Not specified |usefulness_rating=3 |notes=Combination of Temodar and procarbazine showed a high percentage of tumor regressions, suggesting effectiveness. |category=Other Chemotherapy and Cancer Drugs"

2024-03-24T13:11:23Z

Created page with "{{TreatmentInfo |drug_name=Procarbazine |FDA_approval=Yes |used_for=Glioblastoma |clinical_trial_phase=Not specified |common_side_effects=Hematological toxicity, nausea, and neurological effects |OS_with=Not specified |usefulness_rating=3 |notes=Combination of Temodar and procarbazine showed a high percentage of tumor regressions, suggesting effectiveness. |category=Other Chemotherapy and Cancer Drugs"

New page

{{TreatmentInfo
|drug_name=Procarbazine
|FDA_approval=Yes
|used_for=Glioblastoma
|clinical_trial_phase=Not specified
|common_side_effects=Hematological toxicity, nausea, and neurological effects
|OS_with=Not specified
|usefulness_rating=3
|notes=Combination of Temodar and procarbazine showed a high percentage of tumor regressions, suggesting effectiveness.
|category=Other Chemotherapy and Cancer Drugs